Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma

Abstract

Vitamin A deficiency is associated with carcinogenesis, and upregulation of CYP26A1, a major retinoic acid (RA)-catabolizing enzyme, has recently been shown in cancer. We have previously demonstrated alterations of RA biosynthesis in Barrett's oesophagus, the precursor lesion to oesophageal adenocarcinoma. The aims of this study were to determine CYP26A1 expression levels and functional effects in Barrett's associated carcinogenesis. Retinoic acid response element reporter cells were used to determine RA levels in non-dysplastic and dysplastic Barrett's cell lines and endoscopic biopsies. CYP26A1 expression levels, with or without induction by RA and lithocholic acid, were determined by quantitative reverse transcriptase-PCR (RT–PCR) and immunohistochemistry. CYP26A1 promoter activity was determined by a luciferase reporter construct. CYP26A1 was stably overexpressed in GihTERT cells, which were evaluated for gene-expression changes (pathway array and quantitative RT–PCR), cellular proliferation (cytometric DNA profile and colorimetric assay) and invasion (in vitro matrigel assay) with or without the CYP inhibitor ketaconazole. RA levels decreased progressively with the degree of dysplasia (P<0.05) and were inversely correlated with CYP26A1 gene levels and activity (P<0.01). CYP26A1 expression was increased synergistically by RA and lithocholic acid (P<0.05). Overexpression of CYP26A1 led to induction of c-Myc, epidermal growth factor receptor and matrix metalloproteinase 3 as well as downregulation of tissue inhibitor metalloproteinase 1 and 3. Functional effects of CYP26A1 overexpression were increased proliferation (P<0.01) and invasion in vitro (P<0.01), which were inhibited by ketaconazole. Overexpression of CYP26A1 causes intracellular RA depletion and drives the cell into a highly proliferative and invasive state with induction of other known oncogenes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Abu-Abed SS, Beckett BR, Chiba H, Chithalen JV, Jones G, Metzger D et al. (1998). Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha. J Biol Chem 273: 2409–2415.

    Article  CAS  PubMed  Google Scholar 

  • Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ . (2002). Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 97: 1930–1936.

    Article  PubMed  Google Scholar 

  • Bax DA, Siersema PD, Van Vliet AH, Kuipers EJ, Kusters JG . (2005). Molecular alterations during development of esophageal adenocarcinoma. J Surg Oncol 92: 89–98.

    Article  CAS  PubMed  Google Scholar 

  • Bertram JS . (1993). Inhibition of chemically induced neoplastic transformation by carotenoids. Mechanistic studies. Ann NY Acad Sci 686: 161–175; discussion 175–176.

    Article  CAS  PubMed  Google Scholar 

  • Bigg HF, McLeod R, Waters JG, Cawston TE, Clark IM . (2000). Mechanisms of induction of human tissue inhibitor of metalloproteinases-1 (TIMP-1) gene expression by all-trans retinoic acid in combination with basic fibroblast growth factor. Eur J Biochem 267: 4150–4156.

    Article  CAS  PubMed  Google Scholar 

  • Brabender J, Marjoram P, Salonga D, Metzger R, Schneider PM, Park JM et al. (2004). A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus. Oncogene 23: 4780–4788.

    Article  CAS  PubMed  Google Scholar 

  • Chang CL, Lao-Sirieix P, Save V, De La Cueva Mendez G, Laskey R, Fitzgerald RC . (2007). Retinoic acid-induced glandular differentiation of the oesophagus. Gut 56: 906–917.

    Article  CAS  PubMed  Google Scholar 

  • Downie D, McFadyen MCE, Rooney PH, Cruickshank ME, Parkin DE, Miller ID et al. (2005). Profiling cytochrome P450 expression in ovarian cancer: identification of prognostic markers. Clin Cancer Res 11: 7369–7375.

    Article  CAS  PubMed  Google Scholar 

  • Freemantle SJ, Spinella MJ, Dmitrovsky E . (2003). Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22: 7305–7315.

    Article  CAS  PubMed  Google Scholar 

  • Group. MRCOCW (2002). Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 359: 1727–1733.

    Article  Google Scholar 

  • Hormi-Carver K, Feagins LA, Spechler SJ, Souza RF . (2007). All trans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett's cells. Am J Physiol Gastrointest Liver Physiol 292: G18–G27.

    Article  CAS  PubMed  Google Scholar 

  • Klamt F, Dal-Pizzol F, Roehrs R, de Oliveira RB, Dalmolin R, Henriques JA et al. (2003). Genotoxicity, recombinogenicity and cellular preneoplastic transformation induced by vitamin A supplementation. Mutat Res 539: 117–125.

    Article  CAS  PubMed  Google Scholar 

  • Liu T, Bohlken A, Kuljaca S, Lee M, Nguyen T, Smith S et al. (2005). The retinoid anticancer signal: mechanisms of target gene regulation. Br J Cancer 93: 310–318.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lord RV, Tsai PI, Danenberg KD, Peters JH, Demeester TR, Tsao-Wei DD et al. (2001). Retinoic acid receptor-alpha messenger RNA expression is increased and retinoic acid receptor-gamma expression is decreased in Barrett's intestinal metaplasia, dysplasia, adenocarcinoma sequence. Surgery 129: 267–276.

    Article  CAS  PubMed  Google Scholar 

  • Loudig O, Maclean GA, Dore NL, Luu L, Petkovich M . (2005). Transcriptional co-operativity between distant retinoic acid response elements in regulation of Cyp26A1 inducibility. Biochem J 392: 241–248.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Niederreither K, Abu-Abed S, Schuhbaur B, Petkovich M, Chambon P, Dolle P . (2002). Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development. Nat Genet 31: 84–88.

    Article  CAS  PubMed  Google Scholar 

  • Osanai M, Petkovich M . (2005). Expression of the retinoic acid-metabolizing enzyme CYP26A1 limits programmed cell death. Mol Pharmacol 67: 1808–1817.

    Article  CAS  PubMed  Google Scholar 

  • Palanca-Wessels MC, Klingelhutz A, Reid BJ, Norwood TH, Opheim KE, Paulson TG et al. (2003). Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model. Carcinogenesis 24: 1183–1190.

    Article  CAS  PubMed  Google Scholar 

  • Patel JB, Huynh CK, Handratta VD, Gediya LK, Brodie AM, Goloubeva OG et al. (2004). Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice. J Med Chem 47: 6716–6729.

    Article  CAS  PubMed  Google Scholar 

  • Pohl H, Welch HG . (2005). The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 97: 142–146.

    Article  PubMed  Google Scholar 

  • Radominska-Pandya A, Chen G . (2002). Photoaffinity labeling of human retinoid X receptor beta (RXRbeta) with 9-cis-retinoic acid: identification of phytanic acid, docosahexaenoic acid, and lithocholic acid as ligands for RXRbeta. Biochemistry 41: 4883–4890.

    Article  CAS  PubMed  Google Scholar 

  • Reifen R, Nyska A, Koperstein L, Zusman I . (1998). Intestinal and hepatic cell kinetics and mucous changes in vitamin-A-deficient rats. Int J Mol Med 1: 579–582.

    CAS  PubMed  Google Scholar 

  • Saffiotti U, Montesano R, Sellakumar AR, Borg SA . (1967). Experimental cancer of the lung. Inhibition by vitamin A of the induction of tracheobronchial squamous metaplasia and squamous cell tumors. Cancer 20: 857–864.

    Article  CAS  PubMed  Google Scholar 

  • Sah JF, Eckert RL, Chandraratna RA, Rorke EA . (2002). Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation. J Biol Chem 277: 9728–9735.

    Article  CAS  PubMed  Google Scholar 

  • Schoenermark MP, Mitchell TI, Rutter JL, Reczek PR, Brinckerhoff CE . (1999). Retinoid-mediated suppression of tumor invasion and matrix metalloproteinase synthesis. Ann NY Acad Sci 878: 466–486.

    Article  CAS  PubMed  Google Scholar 

  • Shelton DN, Sandoval IT, Eisinger A, Chidester S, Ratnayake A, Ireland CM et al. (2006). Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates via a WNT-dependent mechanism: implications for intestinal cell differentiation and colon tumor development. Cancer Res 66: 7571–7577.

    Article  CAS  PubMed  Google Scholar 

  • Smith AH, Waller KD . (1991). Serum beta-carotene in persons with cancer and their immediate families. Am J Epidemiol 133: 661–671.

    Article  CAS  PubMed  Google Scholar 

  • Van Heusden J, Van Ginckel R, Bruwiere H, Moelans P, Janssen B, Floren W et al. (2002). Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity. Br J Cancer 86: 605–611.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wald N, Idle M, Boreham J, Bailey A . (1980). Low serum-vitamin-A and subsequent risk of cancer. Preliminary results of a prospective study. Lancet 2: 813–815.

    Article  CAS  PubMed  Google Scholar 

  • Webster RP, Gawde MD, Bhattacharya RK . (1996). Effect of different vitamin A status on carcinogen-induced DNA damage and repair enzymes in rats. In Vivo 10: 113–118.

    CAS  PubMed  Google Scholar 

  • Winters CJ, Spurling TJ, Chobanian SJ, Curtis DJ, Esposito RL, Hacker JF et al. (1987). Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92: 118–124.

    Article  PubMed  Google Scholar 

  • Wolbach SB, Howe PR . (1925). Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med 42: 753–777.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wouters W, van Dun J, Dillen A, Coene M-C, Cools W, De Coster R . (1992). Effects of liarozole, a new antitumoral compound, on retinoic acid-induced inhibition of cell growth and on retinoic acid metabolism in MCF-7 human breast cancer cells. Cancer Res 52: 2841–2846.

    CAS  PubMed  Google Scholar 

  • Yung BY . (2004). c-Myc-mediated expression of nucleophosmin/B23 decreases during retinoic acid-induced differentiation of human leukemia HL-60 cells. FEBS Lett 578: 211–216.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Guillermo De La Cueva Mendez for his help and advice and Madhumita Das for her help with the invasion assays.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R C Fitzgerald.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, CL., Hong, E., Lao-Sirieix, P. et al. A novel role for the retinoic acid-catabolizing enzyme CYP26A1 in Barrett's associated adenocarcinoma. Oncogene 27, 2951–2960 (2008). https://doi.org/10.1038/sj.onc.1210969

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210969

Keywords

This article is cited by

Search

Quick links